Patents by Inventor Chunkang TANG

Chunkang TANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12115204
    Abstract: Disclosed are a compound preparation for neuranagenesis, and a preparation method therefor and the use thereof. The compound preparation for neuranagenesis comprises the raw medicinal materials in parts by weight: 10-20 parts of raw Astragali radix, 10-20 parts of Rehmaimiae Radix praeparata, 10-20 parts of Actyranthes bidentata, 6-15 parts of Jujubae fructus, 6-15 parts of Lycii fructus, 6-15 parts of parched Ziziphi spinosae semen, 6-12 parts of Angelicae smensis radix, 3-9 parts of Carthami flos, 6-15 parts of Poria, 6-15 parts of parched Atractylodis macrocephalae rhizoma and 10-20 parts of Zaocys. The compound preparation can be used for preparing drugs to treat nerve damage diseases, and can be prepared into oral liquids, granules, dissolved granules and tablets.
    Type: Grant
    Filed: January 5, 2021
    Date of Patent: October 15, 2024
    Assignee: NANTONG UNIVERSITY
    Inventors: Xiaosong Gu, Chunkang Tang, Fei Ding, Xiaoming Yang, Qiong Cheng, Hualin Sun, Lai Xu
  • Patent number: 11998583
    Abstract: A Fructus Forsythiae and Radix Astragali compound preparation, and a preparation method therefor and a use thereof is provided. Traditional Chinese medicine formulation components consist of the following raw materials or raw material extracts in parts by mass: 9-11 parts of Flos Lonicerae, 9-11 parts of Fructus Forsythiae, 9-11 parts of Radix Scutellariae, 9-11 parts of Herba Artemisiae Annuae, 9-11 parts of Radix Astragali, 9-11 parts of stir-fried Rhizoma Atractylodis Macrocephalae, 9-11 parts of Herba Pogostemonis, 5-7 parts of Radix Saposhnikoviae, 9-11 parts of Radix Ophiopogonis, and 5-7 parts of Radix Glycyrrhizae. The components can be made into an oral liquid, a granule, a dissolved medicine, or a tablet. Further disclosed is a use of the Fructus Forsythiae and Radix Astragali compound preparation in preparation of medicines for preventing and/or treating a viral influenza disease.
    Type: Grant
    Filed: July 14, 2020
    Date of Patent: June 4, 2024
    Assignee: NANTONG UNIVERSITY
    Inventors: Xiaosong Gu, Chunkang Tang, Leilei Gong, Yu Zhang, Qiong Cheng, Xiaoming Yang, Xiaomin Wang
  • Patent number: 11788058
    Abstract: A protein-modified PLGA microsphere can be used to construct tissue-engineered nerve. The microspheres are loaded with active substances for treating peripheral nerve injury and are bound to tissue-engineered nerves. It has been shown that the prepared tissue-engineered nerve effectively promotes nerve regeneration after peripheral nerve injury.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: October 17, 2023
    Assignee: NANTONG UNIVERSITY
    Inventors: Xin Tang, Cheng Sun, Xiaosong Gu, Youlang Zhou, Chunkang Tang
  • Publication number: 20230210936
    Abstract: A traditional Chinese medicine compound preparation for treating Parkinson's disease and its preparation method and application are disclosed. The traditional Chinese medicine compound preparation comprises traditional Chinese medicine formula components and the traditional Chinese medicine formula components comprise the following raw material or raw material extracts by mass: 6-15 parts of uncaria rhynchophylla, 3-9 parts of gastrodia elata, 6-12 parts of Gentiana macrophylla, 10-20 parts of raw astragalus membranaceus, 10-20 parts of prepared rehmannia roots, 10-20 parts of achyranthes roots, 10-20 parts of wolfberry fruits, 10-20 parts of angelica sinensis, 10-20 parts of fried atractylodes macrocephala, 6-15 parts of fried spina date seeds, 3-12 parts of walnut kernels, 3-9 parts of safflower, and 20-30 parts of zaocys dhumnade.
    Type: Application
    Filed: August 5, 2020
    Publication date: July 6, 2023
    Applicant: NANTONG UNIVERSITY
    Inventors: Xiaosong GU, Chunkang TANG, Leilei GONG, Xiaomin WANG, Xin TANG
  • Publication number: 20230040479
    Abstract: A Fructus Forsythiae and Radix Astragali compound preparation, and a preparation method therefor and a use thereof is provided. Traditional Chinese medicine formulation components consist of the following raw materials or raw material extracts in parts by mass: 9-11 parts of Flos Lonicerae, 9-11 parts of Fructus Forsythiae, 9-11 parts of Radix Scutellariae, 9-11 parts of Herba Artemisiae Annuae, 9-11 parts of Radix Astragali, 9-11 parts of stir-fried Rhizoma Atractylodis Macrocephalae, 9-11 parts of Herba Pogostemonis, 5-7 parts of Radix Saposhnikoviae, 9-11 parts of Radix Ophiopogonis, and 5-7 parts of Radix Glycyrrhizae. The components can be made into an oral liquid, a granule, a dissolved medicine, or a tablet. Further disclosed is a use of the Fructus Forsythiae and Radix Astragali compound preparation in preparation of medicines for preventing and/or treating a viral influenza disease.
    Type: Application
    Filed: July 14, 2020
    Publication date: February 9, 2023
    Applicant: NANTONG UNIVERSITY
    Inventors: Xiaosong GU, Chunkang TANG, Leilei GONG, Yu ZHANG, Qiong CHENG, Xiaoming YANG, Xiaomin WANG
  • Publication number: 20230043437
    Abstract: Disclosed are a compound preparation for neuranagenesis, and a preparation method therefor and the use thereof. The compound preparation for neuranagenesis comprises the raw medicinal materials in parts by weight: 10-20 parts of raw Astragali radix, 10-20 parts of Rehmaimiae Radix praeparata, 10-20 parts of Actyranthes bidentata, 6-15 parts of Jujubae fructus, 6-15 parts of Lycii fructus, 6-15 parts of parched Ziziphi spinosae semen, 6-12 parts of Angelicae smensis radix, 3-9 parts of Carthami flos, 6-15 parts of Poria, 6-15 parts of parched Atractylodis macrocephalae rhizoma and 10-20 parts of Zaocys. The compound preparation can be used for preparing drugs to treat nerve damage diseases, and can be prepared into oral liquids, granules, dissolved granules and tablets.
    Type: Application
    Filed: January 5, 2021
    Publication date: February 9, 2023
    Inventors: Xiaosong GU, Chunkang TANG, Fei DING, Xiaoming YANG, Qiong CHENG, Hualin SUN, Lai XU
  • Publication number: 20220213437
    Abstract: A protein-modified PLGA microsphere can be used to construct tissue-engineered nerve. The microspheres are loaded with active substances for treating peripheral nerve injury and are bound to tissue-engineered nerves. It has been shown that the prepared tissue-engineered nerve effectively promotes nerve regeneration after peripheral nerve injury.
    Type: Application
    Filed: June 19, 2020
    Publication date: July 7, 2022
    Inventors: Xin TANG, Cheng SUN, Xiaosong GU, Youlang ZHOU, Chunkang TANG
  • Patent number: 11344594
    Abstract: A fat-soluble extract of Brucea javanica L. Merr is employed in preparing medicines for promoting peripheral nerve regeneration. The fat-soluble extract of Brucea javanica L. Merr is obtained by extraction with a mixed solution of absolute ethanol and ethyl acetate. The present invention finds through research that the fat-soluble extract of Brucea javanica L. Merr promotes the growth of peripheral DRG neurons and neurites, and promotes the division and proliferation of the glial cells, that is, Schwann cells, of the peripheral nervous system, suggesting that the fat-soluble extract of Brucea javanica L. Merr has the effect of promoting peripheral nerve regeneration.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: May 31, 2022
    Assignee: NANTONG UNIVERSITY
    Inventors: Xin Tang, Chunkang Tang
  • Publication number: 20220040247
    Abstract: A fat-soluble extract of Brucea javanica L. Merr is employed in preparing medicines for promoting peripheral nerve regeneration. The fat-soluble extract of Brucea javanica L. Merr is obtained by extraction with a mixed solution of absolute ethanol and ethyl acetate. The present invention finds through research that the fat-soluble extract of Brucea javanica L. Merr promotes the growth of peripheral DRG neurons and neurites, and promotes the division and proliferation of the glial cells, that is, Schwann cells, of the peripheral nervous system, suggesting that the fat-soluble extract of Brucea javanica L. Merr has the effect of promoting peripheral nerve regeneration.
    Type: Application
    Filed: June 19, 2020
    Publication date: February 10, 2022
    Inventors: Xin TANG, Chunkang TANG